Wednesday, July 05, 2017 10:48:24 AM
That "period" was 14 years! Look at the price action and continued toxic financing... what exactly is different post FDA approval here?
"Expect revenues to increase as Actipatch becomes a household name, and investors fight for shares. Everything is timing. The timing now is on investors' side. Hence, this stock is grossly undervalued!"
Sure, revenues may increase but the hole here for investors is deep and getting deeper everyday. The OS is probably around 20 billion now, no one is or will be "fighting for shares".
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM